TBCRC 057: Survey about willingness to participate in cancer clinical trials during the pandemic

ConclusionsWhile pandemic-related anxiety was associated with diminished willingness to participate in trials, the leading reasons for reluctance to consider trial participation were unrelated to the pandemic but included worries about not getting the best treatment, side effects, and delaying care. Patients view trial modifications favorably, supporting continuation of these modifications, as endorsed by the National Cancer Institute and others.

Source: Cancer Medicine - March 11, 2024 Category: Cancer & Oncology Authors: Karen Lisa Smith, Carolyn Mead ‐Harvey, Gina L. Mazza, Eileen H. Shinn, Elizabeth S. Frank, Michelle E. Melisko, Cyd Eaton, Yisi Liu, Jeannine M. Salamone, Teri Pollastro, Patricia A. Spears, Nicole E. Caston, Antonio C. Wolff, Gabrielle Be Tags: RESEARCH ARTICLE Source Type: research